Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

Keywords

Biology, CYP3A5, CYP3A, Single-nucleotide polymorphism, Genetics

References

• Expression of cytochrome P450 3A in amphibian, rat, and human kidney.Massimo Pennesi — 1992
• Characterization of single-nucleotide polymorphisms in coding regions of human genesPedro Navascués Palacio — 1999
• Two linked mutations in transcriptional regulatory elements of the CYP3A5 gene constitute the major genetic determinant of polymorphic activity in humans.Aimée Paulussen, Karel Lavrijsen, Hilde Bohets — 2000
• Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine.Toshifumi Aoyama, Saki Yamano, David J. Waxman — 1989
• The power of point mutationsLynne E. Maquat — 2001
• Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells.Erin G. Schuetz, W T Beck, John D. Schuetz — 1996
• Corticosterone 6 beta-hydroxylase in A6 epithelia: a steroid-inducible cytochrome P-450.William Grogan, Vicki Phillips, Erin G. Schuetz — 1990
• Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).Steven Wrighton, W. Brian, M.-A. Sari — 1990
• Identification of a polymorphically expressed member of the human cytochrome P-450III family.Steven Wrighton, Barbara J. Ring, Paul B. Watkins — 1989
• When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells.Lynne E. Maquat — 1995
• Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism.Mary F. Paine, Mehraneh Khalighi, Jeannine M. Fisher — 1997
• Gene structure of CYP3A4, an adult-specific form of cytochrome P450 in human livers, and its transcriptional control.Hisashi Hashimoto, Kenji TOIDE, Ryuji Kitamura — 1993
• Population distribution and effects on drug metabolism of a genetic variant in the 5′ promotor region of CYP3A4S. Ball, JoAnn Scatina, John Y. Kao — 1999
• The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons.Csaba Finta, Peter G. Zaphiropoulos — 2000
• PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing.Deborah A. Nickerson — 1997
• Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily.Jack Gorski, Stephen D. Hall, D. I. Jones — 1994
• Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver.John D. Schuetz, Deborah L. Beach, Philip S. Guzelian — 1994
• Characterization of a cDNA encoding a new member of the glucocorticoid-responsive cytochromes P450 in human liver.John D. Schuetz, David T. Molowa, Philip S. Guzelian — 1989
• The role of individual human cytochromes P450 in drug metabolism and clinical response.S. Cholerton, Ann K. Daly, Jeffrey R. Idle — 1992
• Pharmacogenomics: translating functional genomics into rational therapeutics.William E. Evans, Mary V. Relling — 1999

Cited by

• Impact of CYP3A5 genotype of recipients as well as donors on the tacrolimus pharmacokinetics and infectious complications after living-donor liver transplantation for Japanese adult recipients.Yuichi Muraki, Masanobu Usui, Shuji Isaji — 2011
• Mutation analysis of the human CYP3A4 gene 5' regulatory region: population screening using non-radioactive SSCP.Josefine Lundvall, Maria Saras-Johansson — 2002
• Pharmacokinetics of midazolam in CYP3A4- and CYP3A5-genotyped subjectsMoch. Jalal, Prof.Dr. Soepomo Poedjosoedarmo — 2004
• The Induction of Cytochrome P450 3A5 (CYP3A5) in the Human Liver and Intestine Is Mediated by the Xenobiotic Sensors Pregnane X Receptor (PXR) and Constitutively Activated Receptor (CAR)*Robert Ashby — 2004
• Activity of cytochrome P450 in childrenMarkus Bräutigam, Dirk Stelzer — 2004
• Predicting drug response and toxicity based on gene polymorphisms.Курышева Ольга Васильевна — 2005
• Pharmacokinetic Considerations Relating to Tacrolimus Dosing in the ElderlyРакитина Мария Сергеевна, Грезина Марина Александровна, Колчина Оксана Александровна — 2005
• Update on pharmacogenetics in epilepsy: a brief review.Ф З Аралбаева, Т В Кузаева — 2006
• Genetic polymorphism of cytochrome P450s and P‐glycoprotein in the Finnish populationAntoinette Derjani Bayeh, Francisco B. P. Moro, Michael J. Smith — 2007
• Comparison of basal gene expression and induction of CYP3As in HepG2 and human fetal liver cells.Masataka Maruyama, Tamihide Matsunaga, Eri Harada — 2007
• Overview of PharmacogeneticsDavid A. Katz — 2006
• CYP3A5 polymorphism and sensitivity of blood pressure to dietary salt in Japanese menChih-Lung Hsiao, Ro‐Min Weng, Kun‐Yi Andrew Lin — 2010
• Developmental pharmacokinetics of etoposide in 67 children: lack of dexamethasone effectR. Voin — 2011
• Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: role of phenolic hydroxyl groups in the resorcinol moiety.Roberto Andorno — 2011
• Association Between CYP3A5 Polymorphisms and Blood Pressure in Kidney Transplant Recipients Receiving Calcineurin InhibitorsElsa Melon — 2011
• Triazole antifungal agents drug–drug interactions involving hepatic cytochrome P450Alejandro Molina, Christopher R. Shaddix — 2011
• Impact of CYP3A5 genetic polymorphism on cross-reactivity in tacrolimus chemiluminescent immunoassay in kidney transplant recipients.A.D. Lane, T.J. Carter, Annamaria Celli — 2012
• Effect of CYP3A51/3 polymorphism on blood pressure in renal transplant recipients.P. J. Sandiford — 2012
• CYP3A4*22: promising newly identified CYP3A4 variant allele for personalizing pharmacotherapy.Н. П. Коцупало, А. Д. Рябцев, А. А. Кураков — 2013
• Pharmacogenetics in solid organ transplantation: genes involved in mechanism of action and pharmacokinetics of immunosuppressive drugs.María del Valle Martínez Ortega, María del Carmen García Parrilla, Ana M. Troncoso — 2013

Related papers

• Composite CYP3A (CYP3A4 and CYP3A5) phenotypes and influences on tacrolimus dose adjusted concentration in adult heart transplant recipientsS Garcia Hernandez, Christina L. Aquilante, Kimberly M. Deininger — 2023
• Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesisElmar Stickeler, Frances Kittrell, Daniel Medina — 1999
• CYP3A5 Genotype and Midazolam Clearance in Australian Patients Receiving ChemotherapyMa‐Li Wong — 2004
• Alternative Splicing and Isoforms: From Mechanisms to DiseasesQi Liu, Leiming Fang, Chengjun Wu — 2022
• Relationships among CYP3A4 and CYP3A5 haplotypes, mRNA expression, CYP3A activity and atorvastatin response in hypercholesterolemic individualsMaria Alice V. Willrich, Fabiana Dalla Vecchia Genvigir, Alice Cristina Rodrigues — 2010
• Динамика активности изоферментов семейства CYP3A при курсовом применении феназепама: влияние полиморфного маркерА CYP3A5*3Д В Иващенко, Smirnov Vv, Kristina Ryzhikova — 2019
• RBM25/LUC7L3 function in Cardiac Sodium Channel Splicing Regulation of Human Heart FailureGe Gao, Samuel C. Dudley — 2012
• Neuron-specific splicing.Nor Hakimah Ab Hakim, Burhanuddin Yeop Majlis, Hitoshi Suzuki — 2017
• Cellular signals modulate alternative splicing.Woan‐Yuh Tarn — 2007
• Influence of CYP3A and ABCB1 polymorphisms on cyclosporine concentrations in renal transplant recipients.Bo Sun, Yankun Guo, Junwei Gao — 2017